Lineage Cell Therapeutics...

AMEX: LCTX · Real-Time Price · USD
0.70
0.10 (15.80%)
At close: May 23, 2025, 3:59 PM
0.68
-2.80%
After-hours: May 23, 2025, 05:51 PM EDT

Lineage Cell Therapeutics Revenue

Lineage Cell Therapeutics reported an annual revenue of $9.5M, reflecting a 6.19% growth. For the quarter ending March 31, 2025, Lineage Cell Therapeutics generated $1.5M in revenue.
Revenue (ttm)
$9.5M
Revenue Growth
6.19%
Price / Sales Ratio
10.59
Revenue / Employee
$135.7K
Employees
70
Market Cap
159.74M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.